DrugPatentWatch Database Preview
Drugs in Development Information for Phosphoric acid
» See Plans and Pricing
What is the drug development status for Phosphoric acid?
Phosphoric acid is an investigational drug.
There have been 7 clinical trials for Phosphoric acid.
The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2011.
The most common disease conditions in clinical trials are Gingival Recession, Dental Caries, and Syndrome. The leading clinical trial sponsors are CrystalGenomics, Inc., Fundação de Amparo à Pesquisa do Estado de São Paulo, and Cairo University.
There are three hundred and sixty US patents protecting this investigational drug and five international patents.
Summary for Phosphoric acid
| US Patents | 360 |
| International Patents | 5,962 |
| US Patent Applications | 389 |
| WIPO Patent Applications | 857 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2011-07-01) |
| Vendors | 45 |
Recent Clinical Trials for Phosphoric acid
| Title | Sponsor | Phase |
|---|---|---|
| Ropivacaine Plasma Concentration With or Without Epinephrine for Posterior Quadratus Lumborum Block | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | N/A |
| Mucoderm® Versus CTG in the Treatment of Multiple Gingival Recessions Associated With Non-carious Cervical Lesion. | Fundação de Amparo à Pesquisa do Estado de São Paulo | N/A |
| Mucoderm® Versus CTG in the Treatment of Multiple Gingival Recessions Associated With Non-carious Cervical Lesion. | Universidade Estadual Paulista Júlio de Mesquita Filho | N/A |
Clinical Trial Summary for Phosphoric acid
Top disease conditions for Phosphoric acid
Top clinical trial sponsors for Phosphoric acid
US Patents for Phosphoric acid
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Phosphoric acid | Start Trial | Colloidal sols of antimony pentoxide in an aqueous medium and their preparation | Laurel Industries, Inc. (Cleveland, OH) | Start Trial |
| Phosphoric acid | Start Trial | Unique bone regeneration tricalcium phosphate | The United States of America as represented by the Secretary of the Army (Washington, DC) | Start Trial |
| Phosphoric acid | Start Trial | Process for preparing ceftazidime pentahydrate | Eli Lilly and Company (Indianapolis, IN) | Start Trial |
| Phosphoric acid | Start Trial | Method for the preparation of 4-acetoxystyrene | Hoechst Celanese Corporation (Somerville, NJ) | Start Trial |
| Phosphoric acid | Start Trial | Alkynylamino-nucleotides | E. I. Du Pont de Nemours and Company (Wilmington, DE) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Phosphoric acid
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Phosphoric acid | Canada | CA1099610 | 1995-08-18 | Start Trial |
| Phosphoric acid | Germany | DE2637185 | 1995-08-18 | Start Trial |
| Phosphoric acid | France | FR2321324 | 1995-08-18 | Start Trial |
| Phosphoric acid | United Kingdom | GB1563214 | 1995-08-18 | Start Trial |
| Phosphoric acid | Italy | IT1065149 | 1995-08-18 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
